Top Health Tech Companies in Atlanta, GA (254)

Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.

Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.

Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.

Strong Revenue Growth: Reported revenue has been rising at a double‑digit pace across fiscal 2025 and the first half of 2026, with both Q1 and Q2 showing solid year‑over‑year increases. Management also raised full‑year 2026 revenue guidance, indicating confidence in continued expansion.

Profitability: Profitability is strong, with adjusted EBITDA growing year over year and margins holding in the low‑40s through fiscal 2025 and recent quarters. The company also reported positive net income and healthy cash generation.

Customer Loyalty & Retention: Net revenue retention remained expansionary and the number of larger clients increased year over year. Subscription revenue grew faster than total revenue in recent periods, suggesting deeper adoption within the existing base.

Strong Revenue Growth: Repeated inclusion on the Inc. 5000 list and an Inc. profile noting 27% three-year growth for 2026 indicate sustained top-line expansion.

Market Expansion: Acquisitions in 2023 (ABA Therapy Billing & Insurance Services) and 2025 (Joshin), plus the addition of a Chief Revenue Officer and an SVP of Enterprise Sales, point to expansion across providers, disability support, and enterprise channels.

Innovation-Driven Growth: New AI-enabled capabilities for behavioral-health workflows and analytics recognition suggest product momentum that supports continued scaling.

Market Expansion: Operations have expanded from 3 to 14 and then 20+ states, with 8,800+ patients served and 17,700+ completed service requests by April 2025. Ongoing recruitment of transportation partners across Georgia and South Carolina underscores continued footprint growth.

Product Line Growth: Offerings now span transportation, interpretation, prescription delivery, post-procedure care, home health, and telemedicine within an integrated coordination platform. This broadened scope indicates expansion beyond a pure NEMT broker into a wider patient-access solution.

Investor Backing & Capital Strength: External sources cite roughly mid–single-digit millions raised across multiple seed rounds, including an oversubscribed Seed-3 in early 2023. Participation in programs with institutions such as Morgan Stanley and Mastercard Start Path signals ongoing investor support.

Strong Revenue Growth: Pre‑take‑private results show recurring revenue increasing and full‑year guidance raised, signaling momentum heading into late 2023–2024. Post‑privatization updates emphasize ongoing launches and customer wins that imply continued focus on growth.

Investor Backing & Capital Strength: Ownership by Thoma Bravo, with Madison Dearborn Partners later joining, is described as providing resources to accelerate product and go‑to‑market execution. This backing supports continued investment despite a mature, competitive market.

Innovation-Driven Growth: The company is rolling out AI capabilities such as Ambient Assist and Navigator, and was recognized by IDC MarketScape for cloud, API integrations, and ambulatory focus. Segment leadership in behavioral health further reflects product advancement in targeted niches.

Healthy Cash Flow: Cash generation has supported consistent deleveraging, with debt reduced across FY2024–FY2025 while maintaining positive operating cash flow. This indicates liquidity resilience despite revenue headwinds.

Market Expansion: New prime awards and vehicle access, including a Navy C5ISR contract and a governmentwide professional services GWAC/IDIQ position, broaden access to defense and civilian missions. Recent NIH task orders further demonstrate entry and traction in adjacent lanes.

Future-Ready Strategy: Investments in AI, cybersecurity, and digital modernization, reinforced by innovation awards and CMMC Level 2 certification, reflect a technology-forward posture. Management’s emphasis on higher‑margin, tech-enabled offerings aligns with evolving federal priorities.

Market Expansion: New Medicaid awards and state entries (e.g., Nevada 2026 and expansions in Mississippi and Michigan) signal continued geographic growth even as the ACA footprint is adjusted. Pursuits in seniors/long‑term care (e.g., New York, Wisconsin LTSS affiliations) further broaden the reach.

Strategic Partnerships: Affiliations and joint ventures (e.g., Common Ground Healthcare Cooperative, Community Care, Lakeland Care, HAP CareSource, and Commonwealth Care Alliance) are expanding capabilities across Medicaid, Marketplace, and complex‑needs segments. These relationships support scale, add lines of business, and position the organization for procurement competitiveness.

Strong Market Position & Advantage: State‑level wins and incumbency retention (e.g., Georgia procurement outcome, large Medicaid presence) reinforce standing in core government programs. Hiring momentum around new launches (e.g., Nevada) suggests confidence in sustained operations and execution capacity.

Strong Market Position & Advantage: Industry materials describe Owens & Minor P&HS as a leading national med‑surg distributor with extensive distribution and manufacturing reach, while Accendra’s Apria and Byram operate at national scale in home‑based care. Recognition from major GPOs signals credibility with large health systems.

Strategic Partnerships: National arrangements such as selection for a preferred DME network and supplier performance awards from Vizient indicate strong channel access. These relationships support volume and reinforce account stickiness with large IDN/GPO customers.

Future-Ready Strategy: Management has repositioned the public company as a pure‑play home‑based care platform and initiated a balance‑sheet optimization to support execution. Maintaining 2026 guidance amid the transition suggests planned continuity while the reset proceeds.

Profitability: Adjusted EPS from continuing operations rose in the latest quarter and gross margin expanded year over year, with materials attributing gains to productivity and mix. Transformation initiatives are presented as supporting margin expansion and earnings growth even when reported sales are muted.

Healthy Cash Flow: Operating cash flow increased meaningfully year to date versus the prior period, and total debt declined, signaling strengthened liquidity. Cash generation is described as improving alongside margin gains.

Strong Market Position & Advantage: Brands such as Huggies and Kleenex hold leading share positions across many countries, and recent updates highlight holding or gaining share in a majority of tracked markets. This footprint and momentum indicate durable category advantage despite competitive intensity.